| Neuroblastoma screening at one year of age FH Schilling, C Spix, F Berthold, R Erttmann, N Fehse, B Hero, G Klein, ... New England Journal of Medicine 346 (14), 1047-1053, 2002 | 551 | 2002 |
| Myeloablative megatherapy with autologous stem-cell rescue versus oral maintenance chemotherapy as consolidation treatment in patients with high-risk neuroblastoma: a … F Berthold, J Boos, S Burdach, R Erttmann, G Henze, J Hermann, ... The lancet oncology 6 (9), 649-658, 2005 | 469 | 2005 |
| Localized infant neuroblastomas often show spontaneous regression: results of the prospective trials NB95-S and NB97 B Hero, T Simon, R Spitz, K Ernestus, AK Gnekow, HG Scheel-Walter, ... Journal of clinical oncology 26 (9), 1504-1510, 2008 | 387 | 2008 |
| Malignancy‐associated haemophagocytic lymphohistiocytosis in children and adolescents K Lehmberg, B Sprekels, KE Nichols, W Woessmann, I Müller, M Suttorp, ... British journal of haematology 170 (4), 539-549, 2015 | 181 | 2015 |
| Long-term results and risk profiles of patients in five consecutive trials (1979–1997) with stage 4 neuroblastoma over 1 year of age F Berthold, B Hero, B Kremens, R Handgretinger, G Henze, FH Schilling, ... Cancer letters 197 (1-2), 11-17, 2003 | 124 | 2003 |
| Regression and progression in neuroblastoma. Does genetics predict tumour behaviour? PF Ambros, IM Ambros, S Strehl, S Bauer, A Luegmayr, H Kovar, ... European Journal of Cancer 31 (4), 510-515, 1995 | 111 | 1995 |
| Expression of mRNA for the neurotrophin receptor trkC in neuroblastomas with favourable tumour stage and good prognosis M Ryden, R Sehgal, C Dominici, FH Schilling, CF Ibanez, P Kogner British journal of cancer 74 (5), 773-779, 1996 | 105 | 1996 |
| Azithromycin: an anti-inflammatory effect in chronic recurrent multifocal osteomyelitis? A preliminary report F Schilling, AD Wagner Zeitschrift fur Rheumatologie 59 (5), 352-353, 2000 | 103 | 2000 |
| Gangliocytes in neuroblastic tumors express alarin, a novel peptide derived by differential splicing of the galanin-like peptide gene R Santic, K Fenninger, K Graf, R Schneider, C Hauser-Kronberger, ... Journal of Molecular Neuroscience 29, 145-152, 2006 | 96 | 2006 |
| Prognostic significance of DNA di‐tetraploidy in neuroblastoma R Ladenstein, IM Ambros, U Pötschger, G Amann, C Urban, FM Fink, ... Medical and Pediatric Oncology: The Official Journal of SIOP—International …, 2001 | 94 | 2001 |
| Low aerobic mitochondrial energy metabolism in poorly-or undifferentiated neuroblastoma RG Feichtinger, F Zimmermann, JA Mayr, D Neureiter, ... BMC cancer 10, 1-9, 2010 | 92 | 2010 |
| The SAPHO syndrome: clinical and radiological differentiation and classification on the basis of 86 cases F Schilling, S Kessler Zeitschrift für Rheumatologie 59, 1-28, 2000 | 82 | 2000 |
| Spondylitis ankylopoetica F Schilling Handbuch der medizinischen Radiologie [Encyclopedia of medical radiology …, 1974 | 78 | 1974 |
| Heterogeneity of the MYCN oncogene in neuroblastoma J Theissen, M Boensch, R Spitz, D Betts, S Stegmaier, H Christiansen, ... Clinical Cancer Research 15 (6), 2085-2090, 2009 | 77 | 2009 |
| Galanin and galanin receptors in human cancers A Berger, R Santic, C Hauser-Kronberger, FH Schilling, P Kogner, ... Neuropeptides 39 (3), 353-359, 2005 | 70 | 2005 |
| Short‐and long‐term outcome of patients with symptoms of spinal cord compression by neuroblastoma T Simon, CA Niemann, B Hero, G Henze, M Suttorp, FH Schilling, ... Developmental Medicine & Child Neurology 54 (4), 347-352, 2012 | 67 | 2012 |
| Das SAPHO-syndrom: klinisch-rheumatologische und radiologische differenzierung und klassifizierung eines Krankengutes von 86 Fällen F Schilling, S Kessler Zeitschrift für Rheumatologie (Print) 59 (1), 1-28, 2000 | 63 | 2000 |
| Combined 111In‐pentetreotide scintigraphy and 123I‐mIBG scintigraphy in neuroblastoma provides prognostic information FH Schilling, H Bihl, H Jacobsson, PF Ambros, T Martinsson, P Borgström, ... Medical and Pediatric Oncology: The Official Journal of SIOP—International …, 2000 | 62 | 2000 |
| Extended induction chemotherapy does not improve the outcome for high-risk neuroblastoma patients: results of the randomized open-label GPOH trial NB2004-HR F Berthold, A Faldum, A Ernst, J Boos, D Dilloo, A Eggert, M Fischer, ... Annals of Oncology 31 (3), 422-429, 2020 | 56 | 2020 |
| Children may not benefit from neuroblastoma screening at 1 year of age. Updated results of the population based controlled trial in Germany FH Schilling, C Spix, F Berthold, R Erttmann, J Sander, J Treuner, ... Cancer letters 197 (1-2), 19-28, 2003 | 56 | 2003 |
